Skip to main content
Journal of Virology logoLink to Journal of Virology
. 2014 Jul;88(13):7569–7577. doi: 10.1128/JVI.00119-14

Residue 41 of the Eurasian Avian-Like Swine Influenza A Virus Matrix Protein Modulates Virion Filament Length and Efficiency of Contact Transmission

Patricia J Campbell a,b, Constantinos S Kyriakis a, Nicolle Marshall a,b, Suganthi Suppiah a, Jill Seladi-Schulman a,b, Shamika Danzy a, Anice C Lowen a, John Steel a,
Editor: D S Lyles
PMCID: PMC4054412  PMID: 24760887

ABSTRACT

Position 41 of the influenza A virus matrix protein encodes a highly conserved alanine in human and avian lineages. Nonetheless, strains of the Eurasian avian-like swine (Easw) lineage contain a change at this position: position 41 of A/swine/Spain/53207/04 (H1N1) (SPN04) encodes a proline. To assess the impact of this naturally occurring polymorphism on viral fitness, we utilized reverse genetics to produce recombinant viruses encoding wild-type M1 41P (rSPN04-P) and consensus 41A (rSPN04-A) residues. Relative to rSPN04-A, rSPN04-P virus displayed reduced growth in vitro. In the guinea pig model, rSPN04-P was transmitted to fewer contact animals than rSPN04-A and failed to infect guinea pigs that received a low-dose inoculum. Moreover, the P41A change altered virion morphology, reducing the number and length of filamentous virions, as well as reducing the neuraminidase activity of virions. The lab-adapted human isolate, A/PR/8/34 (H1N1) (PR8), is nontransmissible in the guinea pig model, making it a useful background in which to identify certain viral factors that enhance transmissibility. We assessed transmission in the context of single-, double-, and triple-reassortant viruses between PR8 and SPN04; PR8/SPN04 M, PR8/SPN04 M+NA, and PR8/SPN04 M+NA+HA, encoding either matrix 41 A or P, were generated. In each case, the virus possessing 41P transmitted less well than the corresponding 41A-encoding virus. In summary, we have identified a naturally occurring mutation in the influenza A virus matrix protein that impacts transmission efficiency and can alter virion morphology and neuraminidase activity.

IMPORTANCE We have developed a practical model for examining the genetics underlying transmissibility of the Eurasian avian-like swine lineage viruses, which contributed M and NA segments to the 2009 pandemic strain. Here, we use our system to investigate the impact on viral fitness of a naturally occurring polymorphism at matrix (M1) position 41 in an Easw isolate. Position 41 has been implicated previously in adaptation to laboratory substrates and to mice. Here we show that the polymorphism at M1 41 has a limited effect on growth in vitro but changes the morphology of the virus and impacts growth and transmission in the guinea pig model.

INTRODUCTION

In 1979, an avian influenza A virus of the H1N1 subtype entered swine populations in Belgium and Germany and established a stable lineage that has since spread across Europe and Asia (13). The resultant Eurasian avian-like swine virus (Easw) lineage continues to circulate in Eurasia today (4). Zoonoses of Easw lineage influenza A viruses to humans are typically self-limiting and clinically mild events (5) that do not lead to sustained human-to-human transmission (610). Nevertheless, the M and NA segments derived from the Easw lineage (11) are important for the highly transmissible phenotype of the 2009 pandemic H1N1 virus (1214). Thus, viruses of the Easw lineage are important for animal health, can cause human disease, and have a demonstrated potential to contribute to the emergence of pandemic strains. Still, very little is known about the genetic and molecular factors that influence the transmission and replication of Eurasian avian-like swine viruses (15).

The influenza A virus matrix (M1) protein is encoded in the bicistronic M gene segment. The protein functions in both virus assembly and budding (1619): it recruits the viral ribonucleoprotein (vRNP) complex to the cell surface during virion assembly (17, 20, 21) and lines the inner surface of the viral membrane. Additionally, M1 provides structural integrity to the influenza virion through interaction with HA and NA glycoproteins (17, 21, 22). The M1 protein is a major determinant of influenza virion morphology (2327).

Clinical isolates of influenza A virus typically include filamentous virions, whereas lab adaptation often produces strains that exhibit an exclusively spherical morphology (24, 28, 29). The biological relevance of filamentous influenza virions is currently unclear. Mutations arising in the M1 gene can convert an exclusively spherical influenza virus to one that produces a pleomorphic mixture of spheres and filaments, and vice versa (2328). Elleman and colleagues (24) reported that the morphologies of the lab-adapted strains A/PR/8/34 and A/WSN/33 differ from that of the human isolate, A/Victoria/3/75, and they mapped the phenotypic difference to matrix protein residues 41, 95, and 218. Roberts and colleagues also demonstrated that residue 41 of the matrix protein affects virion morphology (27). In both of these studies, replacement of the alanine at position 41 with valine led to a loss of filamentous morphology.

Interestingly, an alanine-to-valine polymorphism at residue 41 of the matrix has been identified upon adaptation in mice to multiple influenza A strains (3032). The mutation has been linked to increases in replication and virulence in the mouse model (31, 32).

The SPN04 virus possesses a highly unusual polymorphism at position 41 of the matrix protein, one encoding a proline. A minority of Easw viruses encode a valine at position 41, and the predominant residue is alanine.

We hypothesized that the proline at position 41 of the SPN04 matrix protein alters virion morphology and, although naturally occurring, may attenuate the growth and transmission of the SPN04 virus. By testing this hypothesis, we aimed to shed light on the biological significance of filamentous influenza virions. Our results show that replacement of the widely conserved alanine with proline at position 41 of the matrix protein reduces transmission between guinea pigs, both in the context of the Eurasian avian-like swine virus, A/swine/Spain/53207/04, and in the PR8-based reassortant viruses tested. The A41P mutation concomitantly increased the filament length of each of the viruses.

MATERIALS AND METHODS

Ethics statement.

This study was performed in accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Research Council (33). Animal husbandry and experimental procedures were approved by the Emory University Institutional Animal Care and Use Committee (IACUC protocol 2001001 071214GA).

Cells.

Human tracheo-bronchial epithelial (HTBE) cells, purchased from Lonza, were cultured on Transwell filters at an air-liquid interface and maintained in basal epithelial growth medium (BEGM) supplied to the basolateral chamber as directed by the manufacturer. Madin-Darby canine kidney (MDCK) cells were maintained in minimal essential medium (MEM) supplemented with 10% fetal bovine serum (FBS) and penicillin-streptomycin. 293T cells were maintained in Dulbecco's MEM supplemented with 10% FBS.

Guinea pigs.

Female Hartley strain guinea pigs weighing 300 to 350 g were obtained from Charles River Laboratories. Inoculation and nasal lavage were performed as described previously (34). Prior to all procedures, guinea pigs were sedated with a mixture of ketamine and xylazine (30 mg/kg of body weight and 2 mg/kg, respectively).

Reverse genetics system.

Recombinant virus was generated as previously described (35). Briefly, viral RNA, extracted from A/swine/Spain/53207/04 (H1N1) influenza virus, was reverse transcribed and amplified using influenza virus segment-specific primers (36), resulting in 8 specific cDNA products corresponding to each of the viral gene segments. Six cDNAs (NS, M, NA, NP, HA, and PA) were flanked by LguI restriction enzyme sites. PB1 and PB2 segments were flanked by sequences allowing cloning into the pPol1 plasmid by recombination (37). cDNAs were digested with LguI as appropriate and subsequently cloned by ligation or recombination into the pPol1 plasmid.

Viruses.

A/NL/602/09 (H1N1) (a kind gift of Ron Fouchier) virus is an early 2009 pandemic H1N1 strain that was isolated from a patient in The Netherlands. A/Puerto Rico/8/1934 (H1N1) (PR8)-based and A/swine/Spain/53207/2004 (H1N1) (SPN04)-based viruses were recovered by reverse genetics following previously described procedures (35, 38). Briefly, 8- or 12-plasmid rescue systems, based on pDZ (39) for PR8 (8 plasmids) and pPol1 for SPN04 (12 plasmids, including pCAGGS WSN PA, PB1, PB2, and NP support plasmids), were used to transfect 293T cells. Reassortant viruses were recovered by using the relevant plasmids from both systems (Fig. 1 depicts virus gene constellations). One day after transfection, 293T cells and associated media were collected and injected into 11-day-old embryonated chicken eggs. Stock titers were determined by plaque assay on MDCK cells. A mutation was introduced into the pPol1 SPN04 M segment plasmid that altered residue 41 from a proline to an alanine, generating the pPol1 SPN04 M 41A plasmid. Viruses containing this mutation were rescued in the same manner as described above.

FIG 1.

FIG 1

Schematic diagram of recombinant viruses. Genotypes of each recombinant virus used in the study are depicted. Blue and red bars represent genes from A/PR/8/34 (H1N1) (PR8) and A/Swine/Spain/53207/04 (H1N1) (SPN04) viruses, respectively. The yellow bar indicates the presence of a point mutation encoding a proline-to-alanine change at position 41 of the matrix protein.

Immunostaining and enumeration of plaques.

Characterization of plaque phenotypes on MDCK cells was performed as described previously (40). For immunostaining, polyclonal guinea pig anti-PR8 serum or anti-SPN04 serum (raised in-house) were used as the primary antibodies; horseradish peroxidase-linked anti-guinea pig IgG (Invitrogen) was used as the secondary antibody, and TruBlue (KPL) peroxidase substrate was used for staining. A total of 125 plaques formed by each virus were measured, using ImageJ software, and statistical analyses were performed on the results using Prism software.

Multicycle growth experiments.

MDCK cells were inoculated at a multiplicity of infection (MOI) of 0.002 PFU/cell. Following a 45-min incubation at 37°C, inoculum was removed and monolayers were washed with PBS. Dishes were then incubated at 37°C, and samples of growth medium were collected at 1, 12, 24, 48, and 72 h postinfection (hpi). Titers were determined by plaque assay on MDCK cells.

HTBE cells were washed with PBS to remove mucus and then inoculated at an MOI of 0.001 PFU/cell by adding virus in a 100-μl volume of PBS to the apical surface and incubating at 37°C for 45 min. The inoculum was then removed, and the cells were washed with PBS. At 1, 12, 24, 48, and 72 hpi, virus was collected from the apical surface of the cells by adding 200 μl PBS, incubating at 37°C for 30 min, and then collecting 200 μl of supernatant. Titers were determined by plaque assay on MDCK cells.

Neuraminidase activity.

To compare the neuraminidase activities associated with the viruses, 5 × 105 PFU of each variant was incubated in the presence of the fluorogenic sialoside, 2-(4-methylumbelliferyl)-d-N-acetylneuraminic acid (MUNANA; Sigma), at a final concentration of 150 μM in a total volume of 100 μl. Fluorescence, which is emitted upon cleavage of the MUNANA substrate by the influenza virus neuraminidase enzyme, was detected using a BioTek Synergy H1 plate reader and recorded every minute for 45 min. The slopes of the resultant fluorescence curves of each pair of viruses were compared. Each experiment included triplicate samples for each virus, and experiments were performed at least three times.

Transmission experiments.

In order to assess transmission, four guinea pigs were inoculated by the intranasal route with 103 or, in some cases, 102 PFU of virus in 300 μl PBS. At 24 h postinoculation, infected animals were each placed in a cage with a naive guinea pig. The four cages were subsequently placed within an environmental chamber (Caron 6040) set to 20% relative humidity and 10°C. Nasal washes were collected from all 8 animals on days 2, 4, 6, and 8 postinfection, as previously described (41).

Electron microscopy. (i) Transmission electron microscopy.

For imaging of virions, MDCK cells were inoculated at an MOI of 5. At 18 h postinfection, cells were fixed with 2.5% glutaraldehyde, postfixed with 1% OsO4 and 1.5% potassium ferrocyanide, rinsed with distilled water, and dehydrated through a series of ethanol washes. For transmission electron microscopy (TEM), monolayers were embedded in Eponate 12 resin and stained with 5% uranyl acetate and 2% lead citrate at the Emory Robert P. Apkarian Integrated Electron Microscopy Core facility. After sample preparation, grids were imaged using a Hitachi H-7500 transmission electron microscope and attached charge-coupled device.

(ii) Scanning electron microscopy.

For scanning electron microscopy (SEM), the chips underwent critical point drying in a Polaron E-3000 unit and were fixed to aluminum stubs, coated with 20 nm of chromium, and imaged using a Topcon DS130F scanning electron microscope.

RESULTS

In vitro characterization of recombinant viruses.

By using reverse genetics, a set of eight recombinant viruses was generated. The set comprised the recombinant wild-type (WT) SPN04 (rSPN04-P) and SPN04 M41A (rSPN04-A) viruses, which differed in the identity of residue 41 of the matrix protein (proline or alanine), and six reassortants between A/PR/8/34 (PR8) and SPN04: PR8/SPN04 M, PR8/SPN04 M41A, PR8/SPN04 M+NA, PR8/SPN04 M41A+NA, PR8/SPN04 M+NA+HA, and PR8/SPN04 M41A+NA+HA (Fig. 1). rPR8 virus was rescued as previously described (28). The SPN04 virus rescue system was generated for this study. The cloned SPN04 cDNAs were confirmed to be of the correct size by restriction enzyme digest with XbaI, and each plasmid was fully sequenced to confirm agreement with GenBank accession sequences (CY010584, CY010581, CY010582, CY010583, CY010580, CY010585, CY010586, and CY010587).

(i) SPN04-based viruses.

Initial characterization of the viruses was performed in vitro. In MDCK cells, the biologic and the recombinant wild-type SPN04 viruses grew with comparable kinetics and to similar peak titers of approximately 1 × 108 PFU/ml after 48 h. No significant difference was found between the areas under the curve (AUC) for each virus (log10 9.70 for WT versus log10 9.65 for recombinant virus; P = 0.13 by unpaired t test), confirming that the recombinant virus was not attenuated due to unwanted mutations in the genome (Fig. 2A). Next, the growth of wild-type rSPN04-P and the point mutant rSPN04-A viruses was assayed on fully differentiated HTBE cells cultured at the air-liquid interface and on MDCK cells. In HTBE cells, the average AUC for the rSPN04-A virus was significantly higher than that for the rSPN04-P virus (log10 9.51 versis log10 9.27; P = 0.012 by unpaired t test) (Fig. 2B). Similarly, in MDCK cells the rSPN04-A virus had a significantly higher average AUC than that of the rSPN04-P virus (log10 10.15 versus log10 9.81; P = 0.001 by unpaired t test) (Fig. 2C). Finally, during growth in MDCK cells, a reduction in plaque size attributable to the alanine-to-proline mutation was shown to be statistically significant (P < 0.05; one-way analysis of variance) (Fig. 2E). In summary, the alanine-to-proline substitution in the matrix protein resulted in reduced growth phenotypes of the SPN04 virus in multiple in vitro assays.

FIG 2.

FIG 2

Characterization of recombinant viruses in HTBE and MDCK cells. (A) MDCK cells were infected at a low MOI (0.002) with recombinant PR8, rSPN04, or WT SPN04 viruses. Released virus was collected from the supernatant and enumerated by plaque assay at the indicated time points. (B) HTBE cells were infected at a low MOI (0.001) with recombinant NL602, SPN04-P, or SPN04-A viruses and incubated at 37°C in 5% CO2 for 96 h. Released virus was collected from the apical surface of differentiated cells and enumerated by plaque assay. (C) MDCK cells were infected at a low MOI (0.002) with recombinant PR8, SPN04-P, or SPN04-A viruses. Released virus was collected and enumerated as described for panel A. (D) MDCK cells were infected at a low MOI (0.002) with recombinant PR8, PR8 SPN04 M41P, PR8 SPN04 M41A, PR8 SPN04 M41P+NA, PR8 SPN04 M41A+NA, PR8 SPN04 M41P+NA+HA, or PR8 SPN04 M41A+NA+HA viruses. Each virus possessing a proline at position 41 had marginally delayed kinetics of growth relative to the viruses possessing an alanine at that position. Moreover, PR8 SPN04 M41P and PR8 SPN04 M41P+NA viruses grew to slightly lower peak titers than the isogenic virus possessing alanine at position 41. Released virus was collected from the supernatant and enumerated as described for panel A. The plaque size of each recombinant virus was measured at 48 h postinfection following immunostaining of infected MDCK cells. (E to H) Values for the diameters of at least 125 plaques were plotted for each pair of recombinant viruses as indicated. Statistically significant differences between plaque sizes are denoted by an asterisk (P < 0.05).

(ii) PR8-based reassortant viruses.

Since the lab-adapted PR8 virus does not transmit among guinea pigs, reassortant viruses with a PR8 backbone can be a sensitive platform on which to identify polymorphisms that affect transmission (12, 28). We applied this approach to the SPN04 virus and, because the influenza virus matrix protein is known to interact with the cytoplasmic tails of the influenza virus glycoproteins (19), we evaluated multiple reassortant viruses possessing the HA, NA, and M segments of SPN04, comparing three pairs of viruses possessing the alanine-to-proline substitution in the matrix protein of SPN04, as follows: PR8/SPN04 M and PR8/SPN04 M41A; PR8/SPN04 M+NA and PR8/SPN04 M41A+NA; PR8/SPN04 M+NA+HA and PR8/SPN04 M41A+NA+HA.

Low-multiplicity growth curve experiments performed with MDCK cells demonstrated that viruses possessing the HA, NA, and M segments from SPN04 grew more poorly than other PR8-based viruses, regardless of the nature of the polymorphism at position 41 of the matrix (Fig. 2D), and that there was no significant difference between the AUCs for the pair of 5:3 reassortant viruses (log10 7.15 for PR8/SPN04 M+NA+HA versus log10 7.25 for PR8/SPN04 M41A+NA+HA; P = 0.56 by unpaired t test). Those reassortants carrying the PR8 HA were more fit in MDCK cells than those carrying the SPN04 HA. Given that the WT rSPN04 virus grew to high titers in MDCK cells, the data collectively suggest an incompatibility between the SPN04 HA and gene product(s) of the PR8 virus internal genes. Significant differences were observed between the growth phenotypes of the PR8/SPN04 M and PR8/SPN04 M41A, as well as the PR8/SPN04 M+NA and PR8/SPN04 M41A+NA, virus pairs in MDCK cells (Fig. 2D). PR8/SPN04 M41A virus had a significantly higher average AUC than the PR8/SPN04 M41P virus (log10 8.55 versis log10 7.95; P = 0.0003 by unpaired t test). Similarly, PR8/SPN04 M41A+NA virus had a significantly higher average AUC than PR8/SPN04 M41P+NA virus (log10 8.62 versus log10 8.11; P = 0.001 by unpaired t test).

The plaque size of each of the PR8/SPN04 reassortant viruses was assessed. A total of 125 plaques formed by each virus on MDCK cells were measured. For each virus pair, a statistically significant reduction in plaque size was observed with the PR8/SPN04 virus encoding proline, relative to that encoding alanine, at matrix position 41 (P < 0.05; one-way analysis of variance) (Fig. 2F to H). In summary, the alanine-to-proline substitution in the matrix protein had an attenuating effect on growth phenotypes of the PR8/SPN04 reassortant viruses in vitro, while PR8-based viruses possessing the SPN04 HA grew more poorly than viruses possessing the PR8 HA in MDCK cells.

Morphology of 41P- versus 41A-encoding viruses.

As previous studies demonstrated that an alanine-to-valine polymorphism at position 41 of the matrix protein affects the morphology of multiple influenza A virus strains (23, 24, 27), we wished to examine the effect of the proline-to-alanine change at this position on virion morphology. Using electron microscopy, we studied MDCK cells infected with viruses encoding each amino acid. rSPN04-P exhibited a highly filamentous phenotype in MDCK cells, as observed by either scanning or transmission electron microscopy (Fig. 3A and B). Examples of filaments greater than 10 μm in length were visible by SEM. The mutation of P41 in the rSPN04 virus matrix to A41 altered the morphology of the virion, reducing the length of the filaments from longer than 10 μm to a typical length of approximately 1 μm or less (Fig. 3C and D) (Table 1). rSPN04-P virus yielded 36% of virions greater than 300 nm in length, as measured by TEM, compared to 26% for rSPN04-A virus. Moreover, only the proline-encoding virus displayed filaments greater than 1 μm in length as assayed by TEM. The same trend was observed with two pairs of the PR8/SPN04 reassortant viruses: PR8/SPN04 M41P and PR8/SPN04 M41P+NA possessed 24% and 71% of virions greater than 300 nm in length (Fig. 3A, B, E, and F), as measured by TEM, compared to 4% and 56% for the respective alanine-encoding viruses (Fig. 3C, D, G, and H). Again, only the proline-containing viruses possessed filaments greater than 1 μm in length (Table 1). Surprisingly, for the PR8/SPN04 M 41P+NA+HA and PR8/SPN04 M 41A+NA+HA viruses, the same trends in virion morphology were not observed. Similar to the PR8/SPN04M41P and PR8/SPN04M41P+NA viruses, the proline-containing 5:3 reassortant virus possessed virions greater than 1 μm in length, while the PR8/SPN04 M41A+HA+NA virus did not. Nonetheless, the alanine-containing virus possessed a greater proportion of filamentous virions between 300 nm and 1 μm than the proline-containing variant.

FIG 3.

FIG 3

A proline at residue 41 of matrix protein increases the filament lengths of recombinant viruses. Virion morphologies are shown in representative SEM images (A, C, E, G, I, K, M, and O) or TEM images (B, D, F, H, J, L, N, and P). Adherent MDCK cells were infected at an MOI of 5.0, or mock infected, and incubated for 18 h before fixing and staining. Reassortant viruses possessing a proline at position 41 of the matrix protein (as indicated) exhibited formation of long filamentous virions (A, B, E, F, I, and J). Those viruses possessing alanine at position 41 displayed virions consisting of considerably shorter filaments (C, D, G, H, K, and L). SPN04-P virus displayed pleiomorphic virions, including highly filamentous examples (M and N), whereas SPN04-A produced virions with a markedly reduced length, of approximately 1 μm or less (O and P). Magnification, ×10,000 (A, C, E, G, I, K, M, and O) or ×40,000 (B, D, F, H, J, L, N, and P). Bars, 1.00 μm (A, C, E, G, I, K, M, and O), 0.2 μm (F), or 0.5 μm (B, D, H, J, L, N, and P).

TABLE 1.

Reassortant viruses, measured using TEM, differ in the prevalence of filamentous virions

Morphology Particle length (nm) % of particles of indicated lengtha
SPN04
rPR8/SPN04 M
rPR8/SPN04 M+NA
rPR8/SPN04 M+HA+NA
M1 41P M1 41A M1 41P M1 41A M1 41P M1 41A M1 41P M1 41A
Spherical <100 36 19 45 49 5 17 43 32
100–200 26 31 21 37 18 21 38 38
200–300 2 12 9 10 6 6 8 7
Total 64 74 76 96 29 44 89 77
Filamentous 300–500 10 8.3 6 2 20 15 3 10
500–1,000 20 18 2 2 22 41 4 12
>1,000 6 0 8 0 29 0 4 1
Total 36 26 24 4* 71 56 11** 23.3
Total particles 50 84 86 51 82 78 73 73
a

Among infected, sectioned MDCK cells. *, the percentage of filamentous virions (>300 nm in length) in proline-containing virus was significantly higher (P > 0.05) than in alanine-containing isogenic virions based on a difference of proportions test; **, the percentage of filamentous virions (>300 nm in length) in proline-containing virions was significantly lower (P > 0.05) than in alanine-containing isogenic virions based on a difference of proportions test.

Neuraminidase activity of 41P- versus 41A-encoding viruses.

As we previously had observed a correlation between neuraminidase activity of influenza virions and extent of filamentous morphology (42), we tested whether the NA activity of the matrix 41P-encoding viruses differed from those of the 41A-encoding strains. For this purpose, we used an in vitro assay based on the fluorescent substrate MUNANA. Three of the four pairs of viruses (SPN04, PR8/SPN04 M, and PR8/SPN04 M+NA) showed higher neuraminidase activities in the proline-encoding variants (Fig. 4A, B, and C), and this activity correlated with the presence of higher proportions of virions greater than 300 nm in length (Table 1). Conversely, in the alanine-containing variant of the PR8/SPN04 M+HA+NA virus, the neuraminidase activity was higher than that of the proline-containing variant (Fig. 4D). Notably, in this pair of viruses, it was the 41A variant that had a higher proportion of particles >300 nm in length. Thus, in each case, the neuraminidase activity of the virions correlated with increased filament length.

FIG 4.

FIG 4

A proline at residue 41 of matrix protein increases neuraminidase activity of select recombinant viruses in vitro. The neuraminidase activity of each virus (as indicated) was measured through the cleavage of the fluorogenic substrate MUNANA. Virus was incubated in the presence of MUNANA at 37°C for 45 min, and the relative fluorescence was measured at 1-min intervals. Plots displaying (tightly overlapping) triplicate samples of each virus are shown. Each graph is representative of at least three replicate experiments.

Growth and contact transmission in the guinea pig model.

We employed a guinea pig contact model, as previously described (34, 43), in order to assess the effect of the alanine-to-proline mutation on the infectivity, replication, and transmission of the rSPN04 virus. As shown in Fig. 5A, at an inoculum dose of 1,000 PFU, the inclusion of a proline at position 41 resulted in productive infection with rSPN04-P in three of four guinea pigs, and transmission occurred from one of these animals to a cage mate. By comparison, four out of four animals were infected with rSPN04-A virus at this inoculum dose, and two transmission events occurred (Fig. 5B). Due to the small numbers of animals involved in this experiment, the observed differences had no statistical significance, either in terms of the replication levels or transmission efficiency achieved.

FIG 5.

FIG 5

A proline at residue 41 of matrix protein attenuates growth and transmission of recombinant viruses in guinea pigs. (A) Three out of four guinea pigs inoculated with 1,000 PFU of SPN04-P virus were productively infected, and one transmission to a cage mate occurred on day 6 postinfection. (B) No guinea pigs were productively infected following inoculation with 100 PFU of SPN04-P virus. (C) All guinea pigs inoculated with 1,000 PFU of SPN04-A virus were infected, and two transmission events occurred on day 6 postinfection. (D) Two out of 4 guinea pigs inoculated with 100 PFU of SPN04-A became infected, and one transmission to a cage mate occurred on day 8 postinfection. (E to H) Eight guinea pigs infected with either PR8 SPN04 M41P (E) or PR8 SPN04 M41P+NA (G) virus did not transmit the virus to cage mates. In contrast, guinea pigs infected with PR8 SPN04 M41A (F) or PR8 SPN04 M41A+NA (H) virus displayed an earlier peak of replication and were permissive for 4/8 transmission events. (I) Guinea pigs infected with PR8 SPN04 M41P+NA+HA showed 1/8 transmission events. (J) Animals infected with PR8 SPN04 M41A+NA+HA virus were subject to 5/8 transmission events, although replication kinetics were similar between the two strains (compare graphs in panels I and J). Virus titers were determined by plaque assay from nasal washes collected every 2 days after infection from inoculated (1,000 PFU; dashed lines) and contact-exposed (solid lines) guinea pigs. Virus titers were determined by plaque assay of nasal washes collected every 2 days after infection from inoculated (100 or 1,000 PFU; dashed lines) and contact-exposed (solid lines) guinea pigs. swSp04-A contains the consensus M segment of the Eurasian avian-like swine virus lineage.

At an inoculum dose of 100 PFU, no guinea pigs were infected with the rSPN04-P virus (Fig. 5C), whereas two out of four guinea pigs were infected with the rSPN04-A virus and one accompanying transmission event occurred (Fig. 5D); however, statistically significant differences in replication or transmission were not demonstrated.

Next, we conducted contact transmission experiments involving the PR8-based reassortant viruses. Overall, viruses possessing the SPN04 matrix protein encoding a proline at position 41 transmitted poorly compared to the viruses possessing alanine at this position, broadly reproducing the phenotype observed in the SPN04 genetic background.

The PR8/SPN04 M41P virus did not transmit to any of eight guinea pigs by contact and replicated to approximately 104 to 105 PFU by day 2 postinoculation, as measured in nasal washes (Fig. 5E). In contrast, PR8/SPN04 M41A virus transmitted to four of eight naive cage mates and replicated to peak titers of approximately 106 PFU by day 2 postinfection (Fig. 5F). The PR8/SPN04 M41A virus replicated to significantly higher average titers on day 2 postinoculation (P = 0.0027; unpaired t test) and also had a significantly higher average AUC throughout the period of the infection (P = 0.0189; unpaired t test) than the PR8/SPN04 M41P virus. The cumulative number of transmission events was also significantly different (P = 0.019; unpaired t test). Similarly, the PR8/SPN04 M41P+NA virus did not transmit and replicated to approximately 104 to 105 PFU by day 2 postinfection (Fig. 3G). In contrast, PR8/SPN04 M41A+NA virus transmitted to four of eight naive cage mates and replicated to peak titers of approximately 106 PFU by day 2 postinfection (Fig. 3H). The PR8/SPN04 M41A+NA virus replicated to significantly higher average titers on day 2 postinoculation than the proline-encoding virus (P < 0.0001; unpaired t test), although the average AUC throughout the period of the infection was not significantly different between the two groups of animals (P = 0.78; unpaired t test). The cumulative number of transmission events was, however, significantly different (P = 0.019; unpaired t test).

Consistent with the in vitro data obtained on virus growth, both PR8-based viruses possessing the SPN04 HA replicated to lower levels than the viruses possessing the PR8 HA. Nonetheless, the PR8/SPN04 M41P+NA+HA virus was transmitted to only one of eight cage mates (Fig. 5I), while the PR8/SPN04 M41A+NA+HA virus was transmitted to five out of eight animals (Fig. 5J). The cumulative number of transmission events showed a slight statistical significance (P = 0.04; unpaired t test); however, neither the day 2 nasal wash titers nor the average AUC were significantly different between the two groups of animals. Thus, in each background tested, a lower transmission efficiency was observed for viruses encoding proline at position 41 of the matrix protein than for those encoding alanine.

DISCUSSION

Overall, our results suggest that, dependent upon the specific gene constellation of the virus, the proline residue at position 41 can increase the filamentous nature of the influenza A virion and that this phenotype correlates with a decrease in transmission efficiency, a decrease in replicative capacity, and an increase in neuraminidase activity over an isogenic virus possessing an alanine at matrix position 41.

Among the influenza A virus sequences deposited in GenBank, the proline at position 41 of the matrix protein is unique, encoded only by the SPN04 isolate. However, a few other Eurasian avian-like swine influenza virus strains encode a valine at this position, suggesting that the lineage tolerates polymorphism at this locus to some extent. We have not tested the effect of valine on the morphology of the SPN04 influenza virion.

The structure of the amino-terminal portion (amino acids 2 to 158) of the matrix protein has been solved using X-ray crystallography (44). The crystallized structure consists of nine α-helices and eight loop regions. Position 41 lies within α-helix 3, consisting of amino acids 39 to 48, and is likely solvent exposed. Based on this positioning, the nature of the residue at position 41 could affect oligomerization of the matrix protein or interaction with other viral or cellular factors. Of note, the cyclic nature of the proline side chain is incompatible with the formation of an α-helix, introducing a kink or a break in the structure; thus, α-helix 3 is most likely disrupted in the SPN04 matrix protein.

Several previous studies examined the effects of mutations in the matrix protein on the morphology of the influenza A virus. Lamb and colleagues examined the morphology of influenza A virions by using the A/Udorn/301/72 (H3N2) (A/Udorn) strain (27). A/Udorn possesses an alanine at position 41 of the matrix, in common with the majority of human H3N2 isolates, and is noted for its filamentous nature, with approximately 15% of virions being long filamentous in nature (27). Interestingly, an A41V change in the A/Udorn matrix protein results in a complete loss of filamentous virions, as assayed in gradient-purified virion preparations (27). Similarly, Elleman and colleagues noted that the filamentous human influenza virus isolate A/Victoria/3/75 (H3N2) (A/Victoria) could be altered to a spherical morphology by introduction of a valine at position 41 of the matrix protein (24). In addition, the commonly used laboratory-adapted strains of influenza virus PR8 and A/WSN/33 also possess a valine at position 41 of the matrix protein and are spherical in nature (24, 28). It should be noted, however, that PR8 and A/WSN/33 also possess several other amino acid changes relative to the seasonal H1N1 human influenza A virus consensus sequence, and morphology may be affected by several of these differences. Nonetheless, overall these data suggest the importance of position 41 in determining the morphology of numerous unrelated influenza A viruses.

The alanine-to-valine change in the matrix has been reported in several strains of influenza A virus that are virulent to mice: A/Port Chalmers/1/73 (45), A/FPV/34 (46), A/PR/8/34 (31), and A/WSN/33 (30). Indeed, the mutation was observed to arise during mouse adaptation in the A/Port Chalmers/1/73 background (45). Thus, effects of M1 position 41 on virulence have been demonstrated. We note, however, that in those studies, polymorphism at M1 position 41 arose under circumstances where the selective pressure to transmit had been removed. Thus, here we tested the impact of M1 position 41 on transmission. Replacement of the alanine at position 41 of the Eurasian avian-like swine virus matrix protein with proline reduces viral transmission in a contact model. Interestingly, the reliance of efficient transmission on an alanine at M1 position 41 was evident whether or not its replacement with proline resulted in an observable loss in replicative fitness. These findings are consistent with the idea that an alanine at position 41 is optimal for efficient transmission of influenza A virus.

Evidence that molecular determinants of transmissibility reside within the M segment of influenza virus arose following the 2009 swine-origin pandemic, whereupon an influenza virus strain derived from two parental swine virus lineages that do not possess efficient human transmissibility crossed the species barrier and proceeded to infect over 1 billion people worldwide (47). The unusual genotype of the pandemic strain, encompassing 6 gene segments from the North American TRIG lineage and the M and NA segments from the Eurasian avian-like swine lineage, prompted investigators to study the contribution of the M segment to transmissibility of the pandemic strain. Chou and colleagues demonstrated that the M segment of the pandemic strain A/California/4/2009 restored transmissibility in the guinea pig model to that of the nontransmissible A/Puerto Rico/8/1934 (H1N1) virus (12). Interestingly, A/Puerto Rico/8/1934 encodes valine at position 41 of the matrix protein, whereas A/California/4/2009 encodes an alanine, among several other changes between the two matrix proteins. Further evidence for the importance of the Eurasian origin M segment to transmission of the 2009 pandemic lineage was obtained in ferret (13) and pig (48) models.

Due to the role of the M segment in determining transmission efficiency, we predicted that filamentous influenza virions may be maintained in nature because they are important for transmission. However, our present findings show that viruses carrying M1 41P transmit with lower efficiency than the corresponding, less filamentous variants carrying M1 41A. Nevertheless, we hesitate to conclude that filaments disfavor transmission or that morphology does not affect transmission. A more plausible explanation is that morphology and transmission are linked, but the relationship between particle length and transmissibility is affected (perhaps even mediated by) other viral factors, such as NA activity and HA avidity (42).

Based on our present results, and also those presented in reference 42, we hypothesize that the pleiomorphic nature of avian influenza virus is necessary to support optimal fitness. Thus, spherical and filamentous virions may play complementary and distinct roles within the respiratory tract of the host to promote spread and transmission. Such a mechanism could exploit putative differences in, for example, attachment and release properties of the virions. We furthermore suggest that the proportion, or length, of filaments that supports optimal replication may vary, depending on strain-specific properties of HA and NA.

ACKNOWLEDGMENTS

We thank Peter Palese for the pCAGGS expression plasmid and pPol1 reverse genetics plasmid and Adolfo García-Sastre for the pDZ PR8 rescue system. We are grateful to Gustavo Real-Soldevilla for the A/swine/Spain/53207/04 (H1N1) virus. We also appreciate the work of Hong Yi and Jeannette Taylor of the Robert P. Apkarian Integrated Electron Microscopy Core for TEM and SEM sample processing. We thank the Georgia Research Alliance for support to J.S. and A.C.L. through equipment grants.

This work was funded by the Centers for Excellence in Influenza Research and Surveillance (CEIRS) contract number HHSN266200700006C.

Footnotes

Published ahead of print 23 April 2014

REFERENCES

  • 1.Pensaert M, Ottis K, Vandeputte J, Kaplan MM, Bachmann PA. 1981. Evidence for the natural transmission of influenza A virus from wild ducks to swine and its potential importance for man. Bull. World Health Organ. 59:75–78 [PMC free article] [PubMed] [Google Scholar]
  • 2.Scholtissek C, Burger H, Bachmann PA, Hannoun C. 1983. Genetic relatedness of hemagglutinins of the H1 subtype of influenza A viruses isolated from swine and birds. Virology 129:521–523. 10.1016/0042-6822(83)90194-0 [DOI] [PubMed] [Google Scholar]
  • 3.Chen Y, Zhang J, Qiao C, Yang H, Zhang Y, Xin X, Chen H. 2013. Co-circulation of pandemic 2009 H1N1, classical swine H1N1 and avian-like swine H1N1 influenza viruses in pigs in China. Infect. Genet. Evol. 13:331–338. 10.1016/j.meegid.2012.09.021 [DOI] [PubMed] [Google Scholar]
  • 4.Kyriakis CS, Brown IH, Foni E, Kuntz-Simon G, Maldonado J, Madec F, Essen SC, Chiapponi C, Van Reeth K. 2011. Virological surveillance and preliminary antigenic characterization of influenza viruses in pigs in five European countries from 2006 to 2008. Zoonoses Public Health 58:93–101. 10.1111/j.1863-2378.2009.01301.x [DOI] [PubMed] [Google Scholar]
  • 5.Zell R, Scholtissek C, Ludwig S. 2013. Genetics, evolution, and the zoonotic capacity of European swine influenza viruses. Curr. Top. Microbiol. Immunol. 370:29–55. 10.1007/82_2012_267 [DOI] [PubMed] [Google Scholar]
  • 6.Dacso CC, Couch RB, Six HR, Young JF, Quarles JM, Kasel JA. 1984. Sporadic occurrence of zoonotic swine influenza virus infections. J. Clin. Microbiol. 20:833–835 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.de Jong JC, de Ronde-Verloop JM, Bangma PJ, van Kregten E, Kerckhaert J, Paccaud MF, Wicki F, Wunderli W. 1986. Isolation of swine-influenza-like A(H1N1) viruses from man in Europe, 1986. Lancet ii:1329–1330 [DOI] [PubMed] [Google Scholar]
  • 8.Gregory V, Bennett M, Thomas Y, Kaiser L, Wunderli W, Matter H, Hay A, Lin YP. 2003. Human infection by a swine influenza A (H1N1) virus in Switzerland. Arch. Virol. 148:793–802. 10.1007/s00705-002-0953-9 [DOI] [PubMed] [Google Scholar]
  • 9.Rota PA, Rocha EP, Harmon MW, Hinshaw VS, Sheerar MG, Kawaoka Y, Cox NJ, Smith TF. 1989. Laboratory characterization of a swine influenza virus isolated from a fatal case of human influenza. J. Clin. Microbiol. 27:1413–1416 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Myers KP, Olsen CW, Gray GC. 2007. Cases of swine influenza in humans: a review of the literature. Clin. Infect. Dis. 44:1084–1088. 10.1086/512813 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Smith GJ, Vijaykrishna D, Bahl J, Lycett SJ, Worobey M, Pybus OG, Ma SK, Cheung CL, Raghwani J, Bhatt S, Peiris JS, Guan Y, Rambaut A. 2009. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 459:1122–1125. 10.1038/nature08182 [DOI] [PubMed] [Google Scholar]
  • 12.Chou YY, Albrecht RA, Pica N, Lowen AC, Richt JA, Garcia-Sastre A, Palese P, Hai R. 2011. The M segment of the 2009 new pandemic H1N1 influenza virus is critical for its high transmission efficiency in the guinea pig model. J. Virol. 85:11235–11241. 10.1128/JVI.05794-11 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Lakdawala SS, Lamirande EW, Suguitan AL, Jr, Wang W, Santos CP, Vogel L, Matsuoka Y, Lindsley WG, Jin H, Subbarao K. 2011. Eurasian-origin gene segments contribute to the transmissibility, aerosol release, and morphology of the 2009 pandemic H1N1 influenza virus. PLoS Pathog. 7:e1002443. 10.1371/journal.ppat.1002443 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Yen HL, Liang CH, Wu CY, Forrest HL, Ferguson A, Choy KT, Jones J, Wong DD, Cheung PP, Hsu CH, Li OT, Yuen KM, Chan RW, Poon LL, Chan MC, Nicholls JM, Krauss S, Wong CH, Guan Y, Webster RG, Webby RJ, Peiris M. 2011. Hemagglutinin-neuraminidase balance confers respiratory-droplet transmissibility of the pandemic H1N1 influenza virus in ferrets. Proc. Natl. Acad. Sci. U. S. A. 108:14264–14269. 10.1073/pnas.1111000108 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Kuntz-Simon G, Madec F. 2009. Genetic and antigenic evolution of swine influenza viruses in Europe and evaluation of their zoonotic potential. Zoonoses Public Health 56:310–325. 10.1111/j.1863-2378.2009.01236.x [DOI] [PubMed] [Google Scholar]
  • 16.Wu CY, Jeng KS, Lai MM. 2011. The SUMOylation of matrix protein M1 modulates the assembly and morphogenesis of influenza A virus. J. Virol. 85:6618–6628. 10.1128/JVI.02401-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Rossman JS, Lamb RA. 2011. Influenza virus assembly and budding. Virology 411:229–236. 10.1016/j.virol.2010.12.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Calder LJ, Wasilewski S, Berriman JA, Rosenthal PB. 2010. Structural organization of a filamentous influenza A virus. Proc. Natl. Acad. Sci. U. S. A. 107:10685–10690. 10.1073/pnas.1002123107 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Nayak DP, Balogun RA, Yamada H, Zhou ZH, Barman S. 2009. Influenza virus morphogenesis and budding. Virus Res. 143:147–161. 10.1016/j.virusres.2009.05.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Bui M, Whittaker G, Helenius A. 1996. Effect of M1 protein and low pH on nuclear transport of influenza virus ribonucleoproteins. J. Virol. 70:8391–8401 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Noton SL, Medcalf E, Fisher D, Mullin AE, Elton D, Digard P. 2007. Identification of the domains of the influenza A virus M1 matrix protein required for NP binding, oligomerization and incorporation into virions. J. Gen. Virol. 88:2280–2290. 10.1099/vir.0.82809-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Barman S, Ali A, Hui EK, Adhikary L, Nayak DP. 2001. Transport of viral proteins to the apical membranes and interaction of matrix protein with glycoproteins in the assembly of influenza viruses. Virus Res. 77:61–69. 10.1016/S0168-1702(01)00266-0 [DOI] [PubMed] [Google Scholar]
  • 23.Bourmakina SV, Garcia-Sastre A. 2003. Reverse genetics studies on the filamentous morphology of influenza A virus. J. Gen. Virol. 84:517–527. 10.1099/vir.0.18803-0 [DOI] [PubMed] [Google Scholar]
  • 24.Elleman CJ, Barclay WS. 2004. The M1 matrix protein controls the filamentous phenotype of influenza A virus. Virology 321:144–153. 10.1016/j.virol.2003.12.009 [DOI] [PubMed] [Google Scholar]
  • 25.Burleigh LM, Calder LJ, Skehel JJ, Steinhauer DA. 2005. Influenza A viruses with mutations in the M1 helix six domain display a wide variety of morphological phenotypes. J. Virol. 79:1262–1270. 10.1128/JVI.79.2.1262-1270.2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Bialas KM, Desmet EA, Takimoto T. 2012. Specific residues in the 2009 H1N1 swine-origin influenza matrix protein influence virion morphology and efficiency of viral spread in vitro. PLoS One 7:e50595. 10.1371/journal.pone.0050595 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Roberts PC, Lamb RA, Compans RW. 1998. The M1 and M2 proteins of influenza A virus are important determinants in filamentous particle formation. Virology 240:127–137. 10.1006/viro.1997.8916 [DOI] [PubMed] [Google Scholar]
  • 28.Seladi-Schulman J, Steel J, Lowen AC. 2013. Spherical influenza viruses have a fitness advantage in embryonated eggs, while filament-producing strains are selected in vivo. J. Virol. 87:13343–13353. 10.1128/JVI.02004-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Choppin PW, Murphy JS, Tamm I. 1960. Studies of two kinds of virus particles which comprise influenza A2 virus strains. III. Morphological characteristics: independence to morphological and functional traits. J. Exp. Med. 112:945–952 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Ward AC. 1995. Specific changes in the M1 protein during adaptation of influenza virus to mouse. Arch. Virol. 140:383–389. 10.1007/BF01309872 [DOI] [PubMed] [Google Scholar]
  • 31.Ward AC. 1997. Virulence of influenza A virus for mouse lung. Virus Genes 14:187–194. 10.1023/A:1007979709403 [DOI] [PubMed] [Google Scholar]
  • 32.Smeenk CA, Brown EG. 1994. The influenza virus variant A/FM/1/47-MA possesses single amino acid replacements in the hemagglutinin, controlling virulence, and in the matrix protein, controlling virulence as well as growth. J. Virol. 68:530–534 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.National Research Council. 2011. Guide for the care and use of laboratory animals, 8th ed. National Academies Press, Washington, DC [Google Scholar]
  • 34.Lowen AC, Mubareka S, Tumpey TM, Garcia-Sastre A, Palese P. 2006. The guinea pig as a transmission model for human influenza viruses. Proc. Natl. Acad. Sci. U. S. A. 103:9988–9992. 10.1073/pnas.0604157103 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Fodor E, Devenish L, Engelhardt OG, Palese P, Brownlee GG, Garcia-Sastre A. 1999. Rescue of influenza A virus from recombinant DNA. J. Virol. 73:9679–9682 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Hoffmann E, Stech J, Guan Y, Webster RG, Perez DR. 2001. Universal primer set for the full-length amplification of all influenza A viruses. Arch. Virol. 146:2275–2289. 10.1007/s007050170002 [DOI] [PubMed] [Google Scholar]
  • 37.Liu Q, Wang S, Ma G, Pu J, Forbes NE, Brown EG, Liu JH. 2009. Improved and simplified recombineering approach for influenza virus reverse genetics. J. Mol. Genet. Med. 3:225–231 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Steel J, Lowen AC, Mubareka S, Palese P. 2009. Transmission of influenza virus in a mammalian host is increased by PB2 amino acids 627K or 627E/701N. PLoS Pathog. 5:e1000252. 10.1371/journal.ppat.1000252 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Quinlivan M, Zamarin D, Garcia-Sastre A, Cullinane A, Chambers T, Palese P. 2005. Attenuation of equine influenza viruses through truncations of the NS1 protein. J. Virol. 79:8431–8439. 10.1128/JVI.79.13.8431-8439.2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Gao Q, Brydon EW, Palese P. 2008. A seven-segmented influenza A virus expressing the influenza C virus glycoprotein HEF. J. Virol. 82:6419–6426. 10.1128/JVI.00514-08 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Lowen AC, Mubareka S, Tumpey TM, García-Sastre A, Palese P. 2006. The guinea pig as a transmission model for human influenza viruses. Proc. Natl. Acad. Sci. U. S. A. 103:9988–9992. 10.1073/pnas.0604157103 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Campbell PJ, Danzy S, Kyriakis CS, Deymier MJ, Lowen AC, Steel J. 2014. The M segment of the 2009 pandemic influenza virus confers increased neuraminidase activity, filamentous morphology, and efficient contact transmissibility to A/Puerto Rico/8/1934-based reassortant viruses. J. Virol. 88:3802–3814. 10.1128/JVI.03607-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Lowen AC, Steel J, Mubareka S, Palese P. 2008. High temperature (30 degrees C) blocks aerosol but not contact transmission of influenza virus. J. Virol. 82:5650–5652. 10.1128/JVI.00325-08 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Sha B, Luo M. 1997. Structure of a bifunctional membrane-RNA binding protein, influenza virus matrix protein M1. Nat. Struct. Biol. 4:239–244. 10.1038/nsb0397-239 [DOI] [PubMed] [Google Scholar]
  • 45.Zebedee SL, Lamb RA. 1989. Nucleotide sequences of influenza A virus RNA segment 7: a comparison of five isolates. Nucleic Acids Res. 17:2870. 10.1093/nar/17.7.2870 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Scholtissek C, Vallbracht A, Flehmig B, Rott R. 1979. Correlation of pathogenicity and gene constellation of influenza A viruses. II. Highly neurovirulent recombinants derived from non-neurovirulent or weakly neurovirulent parent virus strains. Virology 95:492–500 [DOI] [PubMed] [Google Scholar]
  • 47.Van Kerkhove MD, Hirve S, Koukounari A, Mounts AW. 2013. Estimating age-specific cumulative incidence for the 2009 influenza pandemic: a meta-analysis of A(H1N1)pdm09 serological studies from 19 countries. Influenza Other Respir. Viruses 7:872–886. 10.1111/irv.12074 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Ma W, Liu Q, Bawa B, Qiao C, Qi W, Shen H, Chen Y, Ma J, Li X, Webby RJ, Garcia-Sastre A, Richt JA. 2012. The neuraminidase and matrix genes of the 2009 pandemic influenza H1N1 virus cooperate functionally to facilitate efficient replication and transmissibility in pigs. J. Gen. Virol. 93:1261–1268. 10.1099/vir.0.040535-0 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES